Personalized Drug Response Profiling for Patient-Derived CLL cells via Miniaturized Gene Expression and Drug Sensitivity Testing on Droplet Microarray

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Notes: Karlsruhe, Karlsruher Institut für Technologie (KIT), Dissertation, 2024

Keyword: Krebs

Event: Veröffentlichung

(where): Karlsruhe

(who): KIT-Bibliothek

(when): 2025

Creator: El Khaled El Faraj, Razan

Contributor: Levkin, Pavel A. A.
Hilbert, Lennart

DOI: 10.5445/IR/1000178982

URN: urn:nbn:de:101:1-2502260402033.591543242658

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

El Khaled El Faraj, Razan
Levkin, Pavel A. A.
Hilbert, Lennart
KIT-Bibliothek

Time of origin

2025

Other Objects (12)

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Hochschulschrift

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Hochschulschrift

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Hochschulschrift

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Personalized Drug Response Profiling for Patient-Derived CLL cells via Miniaturized Gene Expression and Drug Sensitivity Testing on Droplet Microarray

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery

Miniaturized Drug Discovery Assays Targeting Macrophages in Fibrotic Diseases

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Multiplexed combinatorial drug screening using droplet-based microfluidics

Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

Drug interactions and response in patient-derived colorectal cancer organoids

Patient-derived xenografts: a relevant preclinical model for drug development

In vitro drug testing using patient-derived ovarian cancer organoids

Drug dosage for microneedle-based transdermal drug delivery systems utilizing evaporation-induced droplet transport

In silico modeling predicts drug sensitivity of patient-derived cancer cells

Correction: In vitro drug testing using patient-derived ovarian cancer organoids

Droplet‐Microarray: Miniaturized Platform for High‐Throughput Screening of Antimicrobial Compounds

Related objects

Reset password